MedTrace Logo

Bupivacaine Alone vs Bupivacaine and Dexmed in Cesarean Deliveries

NCT05469529 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-07-21

No results posted yet for this study

Summary

The purpose of the study is to compare the onset and duration of sensory and motor block after spinal anesthesia between intrathecal bupivacaine alone vs intrathecal bupivacaine and dexmedetomidine combination.

Conditions

  • Dexmedetomidine

Interventions

DRUG

Dexmedetomidine

5mcg dexmedetomidine to be given intrathecally along with 0.5% bupivacaine.

Sponsors & Collaborators

  • KRL Hospital, Islamabad

    lead OTHER

Principal Investigators

  • Rida Qureshi · KRL Hospital, Islamabad

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-15
Primary Completion
2022-09-15
Completion
2022-10-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05469529 on ClinicalTrials.gov